A detailed history of Avoro Capital Advisors LLC transactions in Cerevel Therapeutics Holdings, Inc. stock. As of the latest transaction made, Avoro Capital Advisors LLC holds 7,539,547 shares of CERE stock, worth $0. This represents 4.21% of its overall portfolio holdings.

Number of Shares
7,539,547
Previous 7,555,555 0.21%
Holding current value
$0
Previous $319 Million 3.47%
% of portfolio
4.21%
Previous 3.85%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$38.96 - $42.75 $623,671 - $684,342
-16,008 Reduced 0.21%
7,539,547 $308 Million
Q4 2023

Feb 14, 2024

BUY
$20.27 - $42.44 $134 Million - $280 Million
6,600,000 Added 690.7%
7,555,555 $320 Million
Q3 2023

Nov 14, 2023

BUY
$20.26 - $31.91 $19.4 Million - $30.5 Million
955,555 New
955,555 $20.9 Million

Others Institutions Holding CERE

About Cerevel Therapeutics Holdings, Inc.


  • Ticker CERE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 155,752,000
  • Description
  • Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, engages in the development of various therapies for neuroscience diseases. It is developing emraclidine, a positive allosteric modulator (PAM) that is in phase 1b clinical trials for the treatment of schizophrenia; and Darigabat, a PAM, which is in Phase 2 proof-of-...
More about CERE
Track This Portfolio

Track Avoro Capital Advisors LLC Portfolio

Follow Avoro Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avoro Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avoro Capital Advisors LLC with notifications on news.